AL

Alistair Ian Longshaw

RE Respivert: 3 patents #6 of 28Top 25%
TL Topivert Pharma Limited: 2 patents #1 of 19Top 6%
AM Albert Einstein College Of Medicine: 1 patents #7 of 62Top 15%
VL Victoria Link: 1 patents #4 of 12Top 35%
Overall (2016): #47,829 of 481,213Top 10%
4
Patents 2016

Issued Patents 2016

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
9493465 3-hydroxypyrrolidine inhibitors of 5′-methylthioadenosine phosphorylase and nucleosidase Gary Brian Evans, Vern L. Schramm, Peter Charles Tyler 2016-11-15
9475796 1-pyrazolyl-3-((4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitors Kazuhiro Ito, Catherine Elisabeth Charron, John King-Underwood, Stuart Thomas Onions 2016-10-25
9447076 Inhibitor of p38 map kinase Euan Alexander Fraser Fordyce, Stuart Thomas Onions, John King-Underwood, Jennifer D. Venable 2016-09-20
9249125 Pyrazole derivatives as p38 MAP inhibitors Lorna Duffy, John King-Underwood, Peter John Murray, Stuart Thomas Onions, David Michael Adrien Taddei +3 more 2016-02-02